STAT | Reporting from the frontiers of health and medicine Follow STAT+: Monopar resurrects a shelved Wilson disease drug. Spotting a possible math problem helped AstraZeneca abandoned a rare disease drug, but a co-inventor believes the company made a formula error in analyzing clinical data. https://www.statnews.com/2025/10/09/monopar-therapeutics-wilson-disease-astrazeneca/ statnews.com
